A review of evidence, published in July’s Clinical and Experimental Optometry, indicates the eye is an unlikely site for SARS‐CoV‐2 infection, suggesting coronaviruses are not likely to bind to ocular surface cells to initiate infection.
Infection control remains a critical and ongoing requirement for safe optometry practise across Australia and particularly in Victorian hotspots where stage three restrictions have now been re introduced, Optometry Australia has reminded optometrists.
Adelaide optometrist José Estevez is part of a team granted $1.4 million government funding to improve detection, screening and treatment of diabetic retinopathy in Aboriginal and Torres Strait Islander people.
Doctors’ Health Fund CEO Peter Aroney discusses how private health insurance has responded in the complex environment of COVID–19 pandemic, its opportunities, challenges, and what he sees ahead for the industry.
Two optometrists studying their PhDs at UNSW are the recipients of prestigious awards from the American Academy of Optometry Foundation.
Queensland optometrists Dr Julie Albietz and Associate Professor Katrina Schmid are the recipients of Clinical and Experimental Optometry’s 2020 J Lloyd Hewett Outstanding Paper Award.
Optometry Australia members have the opportunity to participate in a quick survey about the Visiting Optometrists Scheme (VOS), with the Commonwealth Department of Health currently reviewing the Service Delivery Standards.
A cardboard desktop resource to encourage optometrists and practice staff to ask patients if they identify as Aboriginal or Torres Strait Islander is coming free to every member in the June edition of Pharma.
An iPad app allowing regular home monitoring by AMD and glaucoma patients enables them to detect vision changes, prompting them to seek help from their optometrist.
Optometry Australia has compiled coronavirus and infection control advice for optometrists and their staff to assist them to return to work safely and protect patients.
